Showing 1-1 of about 1 articles.
Lixte Biotechnology Holdings, Inc.
EAST SETAUKET, NY , Oct. 09, 2018 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced that it has submitted an IND to the FDA to conduct a Phase 1b/2 trial of the safety ...
Showing 1-1 of about 1 articles.